Polyphosphate-crosslinked hydrogels: structural design and bioactivity for tissue engineering scaffolds.

Authors

Xiaoyu Cao, Qiongwen Liang

Published in

RSC advances. Aug 14, 2026. Epub Aug 14, 2026.

Abstract

Infected chronic wounds present complex pathophysiology characterized by persistent bacterial colonization and impaired tissue regeneration, necessitating multifunctional biomaterials for integrated therapeutic intervention. This study developed a polyphosphate-crosslinked hydrogel system via zinc ion-mediated crosslinking of sodium polyphosphate and sodium alginate, with co-loading of ampicillin and transforming growth factor-β₁ (TGF-β₁). The hydrogel achieved loading efficiencies of 85.2 ± 2.5% for ampicillin and 78.6 ± 1.2% for TGF-β₁, with optimized swelling properties and mechanical characteristics suitable for soft tissue engineering. In vitro evaluations demonstrated potent bactericidal activity against Escherichia coli with bacterial load reduction exceeding 4 log₁₀ CFU mL^-1 within 24 hours, enhanced human dermal fibroblast proliferation to 222.5% at 96 hours, and significant anti-senescence efficacy with SA-β-gal-positive cells reduced to 24.2%. Mechanistically, the therapeutic effects were attributed to complementary actions where ampicillin eliminated bacterial threats while TGF-β₁ promoted fibroblast proliferation, collagen synthesis, and inflammatory resolution. This multifunctional scaffold platform demonstrates promising potential for advanced wound management, including applications in wound dressings, burn treatment, and tissue regeneration.

PMID:
42602601
Bibliographic data and abstract were imported from PubMed on 15 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.